echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > From Kanghua to Kantai, is this an era when "Kang" must catch fire?

    From Kanghua to Kantai, is this an era when "Kang" must catch fire?

    • Last Update: 2020-09-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Only buy roses on Valentine's Day, not necessarily not really romantic, only chasing hot money is the real speculation.
    day of trading, Kantai Medical's shares closed down 17.4 percent.
    Kantai medicine to thermometer, blood oxygen products accounted for the first half of the outbreak, but with the development of vaccines, the latter can continue to succeed, it remains to be seen.
    6.72 per cent after the semi-annual report.
    , which has a strong track record with rabies vaccines, may have reacted in stocks to the clinical trials of seven companies that have authored the double-cell rabies vaccine.
    is not enough to be strong, stronger than the opponent to survive, the winner eat.
    17 plunged 6.6 percent after the company reported a loss of more than $100 million in its half-yearly report.
    is like a straight man comforting a broken-up friend when the common sentence, "this is no way."
    , as a medical institution, the first half of the tragedy can be imagined.
    hospital limited flow, outpatients need to open their mouths to measure nucleic acid, although once fire to swallow swabs cotton swabs are not available, but the number of hospital visits is a real reduction.
    finally under the mask Chinese slowly found that some patients do not go to the hospital do not take medicine, can even heal;
    If Qilu Pharmaceuticals' Siddinna offer is the last illusion to break through those doped medical devices, the mask is definitely taking away the first half of the rations of most drug companies and medical institutions.
    drug companies that have cut production have no chance to mourn, because what awaits is the harvest.
    don't say that maybe a penny won't earn, to take into account people's livelihood, as for your survival of medicine, that is another category.
    when you look forward to cutting the middle price of the drug substitute, the knife has actually reached out to the production of general workers, quality inspection team chief body.
    a five-cent pill, I don't believe a lot of people can't afford it.
    if profits really reach the stage where they must be cut to the point, then pharmaceutical companies are afraid of no one to follow.
    of course, many colleagues will say, "contentment bar, can gather is after the consistent evaluation, but the consistency evaluation, collection has no chance."
    , however, this may be an illusion.
    hainan Province has made a plan, the same generic name has not yet been generic drugs through the quality and efficacy of consistent evaluation of drugs, through the form of expert selection to determine the procurement of varieties.
    does hainan mean? That means if everyone doesn't agree, then we all have a chance to get in there and do it now.
    according to crosstalk, can not enter the collection "all rely on peer help lining."
    do not know those consistency to go too fast head enterprises will not feel the loss, did not expect "slow" is also a way to success.
    don't forget that Enhua Pharmaceuticals' chlorine-nitrogen tablets were selected at 0.016 yuan per tablet, according to its announced 6.68 million yuan consistent evaluation costs, need to sell 400 million tablets to recover costs.
    but Hainan's mode of operation, is most likely a supplement, is afraid that no medicine is available.
    if the consistent medicine collected is out of stock, it will have to have a spare tire.
    if you're a little sister's spare tire, it's a spare tire, and if you're a 10,000-year-old sister's spare tire, then the little sister is your spare tire.
    this is the reason that quantity change causes qualitative change, smart as you, must understand very well.
    , whether it's collected or not, the days of eating meat in large chunks are long gone.
    when a person's main business is not enough, they choose to work part-time;
    the impact of the new crown epidemic and volume procurement, many enterprises can lift the profit decline report card to face the shareholders, "this is no way."
    long-term stability of a company's personnel is not necessarily a good thing, but frequent changes in the top level must not be a good thing.
    the first half of this year, the board of supervisors of a pharmaceutical company changed frequently, with six new supervisory directors and the departure of two supervisory directors, and the results were indeed worrying, with first-half net profit falling by 36% over the same period.
    but the same movement of people is not only this family, so at home, foreign countries can not be spared.
    24 Teva Pharmaceuticals announced 350 job cuts in response to the current generic competition, Japan's largest pharmaceutical company Takeda Pharmaceuticals also reported plans to lay off workers.
    set, have you finished your eggs? Domestic did not happen similar big news, it can be said that on the one hand, the first-line production, low-wage system of quality personnel offset part of the impact, on the other hand, pharmaceutical companies in the constant pressure, nerves have been tired numb.
    first half of this year, Jichuan Pharmaceuticals, Kangzhi Pharmaceuticals, Jinshi Ya Pharmaceuticals, Dongsian, China Resources 39 revenue decline in the range of about 20%.
    large enterprises have the financial strength to survive the season of no longer cold, small businesses do not have so many opportunities.
    you can't blame a single enterprise product, after all, most of them are thinking of relying on exclusive pillar products to survive.
    play small and beautiful, unique and refined characteristics of products, this is not exactly advocated by the state? Children are too obedient, not a good thing, and so are businesses.
    you have not been able to change others "because of illness and poverty", but they have embarked on the "fighting poverty" situation.
    can't deny your hard work, but you can't get out of the poverty of life.
    millions of drugmakers want to get a practicing pharmacist to make money, but the money may be only a small part.
    A computer can not be turned on, need to replace the power supply, power prices dozens of pieces, replacement labor costs also have dozens;
    you all say it's a technical barrier, people should be worth the price, practicing pharmacists? Selling high-priced drugs is unprofessional, you would tell him to sell the bottom price set of drugs to take what to do labor costs ah? Technical barriers have become worthless here.
    part of the responsibility for people's health is assosted to pharmaceutical companies and pharmacists, but it does not give enough dignity to stand up and earn money.
    money is always earned, either legitimate or gambling.
    time, I particularly understand those who cut vegetables, they have data fraud, some falsely reported the new crown vaccine in the study.
    but understanding, these people still have to be severely punished.
    this belongs to the overdraft of the entire industry of credit to their own profits, money earner, should not have such a means of making such a down.
    people's health, everyone yearns for, but the health care stock market boom can not replace the normal development of enterprise products.
    the stock market to make money and products to make money, these are two concepts, but also two different directions.
    can even be said to be about the future of enterprises and public health care needs.
    to cool down properly, don't let the stock market represent industry.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.